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500 MHz iH NMR studies of human epidermal growth factor are described. The backbone resonances of 
the l-48 derivative of hEGF have been assigned using two-dimensional techniques. Analysis of the type 
and magnitude of the observed sequential nuclear Overhauser effects and the NH-c&H spin-spin coupling 
constants allowed prediction of the secondary structure. Aspects of the tertiary structure are also identified. 
A pair of antiparallel B-sheets involving residues 18-23 and 28-34 is a dominant feature of the solution 
structure. 
Growth factor (Human EGF) NMR Protein structure 
1. INTRODUCTION 
Human epidermal growth factor (hEGF), also 
known as urogastrone, is a protein of 53 amino 
acids with three disulphide bridges [l]. EGF in- 
hibits gastric acid secretion [2] and is thought to 
play an important part in the growth and differen- 
tiation of cells [3]. It is homologous to epidermal 
growth factors isolated from other mammals [4,5] 
and to other growth factors [6]. EGF-like se- 
quences have also been observed to form domains 
in several other extracellular proteins [7]. No 
detailed crystal structure is available for EGF or 
any other member of this family of related 
proteins. 
The solution structures of small proteins can 
now be determined from NMR data [8]. Some 
NMR studies of murine EGF have been published 
[9,10], but relatively few assignments were made 
and conclusions about the protein structure were 
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limited. We describe here NMR studies of the l-48 
fragment of hEGF which retains virtually complete 
biological activity in vivo. A complete assignment 
of the observable NH and cvCH resonances has 
been achieved and will be reported in detail in a 
later paper. In this paper we present an analysis of 
the observed nuclear Overhauser effects (NOE) 
and the NH-&H spin-spin coupling constants. 
Slowly exchanging hydrogens have also been iden- 
tified and related to hydrogen bonding patterns. 
These procedures, which have been discussed in 
detail elsewhere [ 1 I], have allowed several features 
of the secondary and tertiary structure of hEGF to 
be identified. 
2. MATERIALS AND METHODS 
hEGF, with a polyarginine tail at the C- 
terminus, was produced in by G.D. 
recombinant DNA techniques [12]. The 
hEGF and the l-48 derivative were obtained by 
trypsin treatment of this material and then purified 
by ion-exchange and gel-exclusion chroma- 
tography [13]. The lyophilised powder was dis- 
solved in 10% D~0/90% Hz0 or in 100% D20 to 
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give a protein concentration of about 8 mM. The 
1-53 derivative was found to be less soluble and 
solutions of around 2 mM were studied. The solu- 
tions were titrated with DC1 to a pH of 3.0-3.1 
(uncorrected meter reading). 
‘H NMR spectra were recorded at 30°C and the 
shifts are quoted with reference to 3-trimeth- 
ylsily1[2,2,3,3-‘HI-propionate. spectra were ac- 
quired with a Bruker AM500 spectrometer or a 
500 MHz spectrometer assembled in this 
laboratory equipped with a Nicolet/GN 1280 com- 
puter and an Oxford Instruments magnet. Two- 
dimensional NOESY [ 141 and COSY [15] spectra 
were acquired in the phase sensitive mode with 
quadrature detection in Fi achieved by the method 
of States et al. [16] or by TPPI [17]. Relayed 
coherence transfer (RCT) spectra [18] were ac- 
quired in the absolute value mode with the phase 
cycling scheme of Bax and Drobny [ 191 and delays 
of 30 and 50 ms between the second and third 90” 
pulses. 
3. RESULTS AND DISCUSSION 
This study was mainly carried out using a 
derivative of the native hEGF; it is thus necessary 
to consider the relevance of its structure. High 
resolution 500 MHz 1D NMR spectra of the l-48 
and l-53 peptides were carefully compared. 
Although the deleted pentapeptide contains two 
tryptophans, only small changes in shift were 
observed for all the remaining methyl group and 
aromatic resonances. This suggests that the 49-53 
pentapeptide is not very intimately associated with 
the remainder of the protein. Previous photo- 
CIDNP experiments on murine EGF [20] also in- 
dicated that Trp-49 and Trp-50 are solvent expos- 
ed. In addition, experiments on the biological ac- 
tivity of the l-47 peptide [ 131 and the l-48 peptide 
(H. Gregory, unpublished) show that, while these 
peptides are less potent than hEGF as mitogens, 
the effects on gastric acid secretion are com- 
parable. There is thus good reason to suppose that 
structural conclusions about the 1-48 fragment 
will have validity for the native protein. 
Determination of the secondary structure of a 
protein from NMR data requires the backbone NH 
and uCH resonances to be assigned [21]. The pro- 
cedure used to identify the spin systems of the 
amino acids was to collect and analyse COSY and 
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RCT spectra, with some additional assistance from 
NOESY spectra. In fig.1 the COSY cross peaks 
between the NH and &H resonances of residues 
29-35 are indicated. 
Spin systems of residues which are adjacent in 
the protein chain were identified by NOES from 
backbone NH resonances of one residue to 
resonances of the NH, &H and flCH groups of 
the preceding residue [21]. A compilation of this 
information leads to sequence specific assignment 
for the spin system of each amino acid. Some of 
the observed sequential NOES observed for 
residues 29-34 are shown in fig. 1. 
Sequential NOES are classified as &N (between 
&HIi and NHi+ i), dNN (between NHi and NHi+ 1) 
and dpN (between @Hi and NHi+t). A list of se- 
quential NOES observed in the 1-48 fragment of 
hEGF is given in fig.2. Examination of this figure 
shows that one or more connectivity is observed 
for all the residues except where overlap of the 
Ser-4, Cysd and Tyr-22 &H resonances with the 
Hz0 resonance prevented direct observation of se- 
quential NOES to Glu-5, Pro-7 and Be-23. (In the 
case of Cysd, the sequentia1 NOE would be to the 
KH resonances of Pro-7.) 
Slowly exchanging amide protons and approx- 
imate values for several NH-&H coupling con- 
stants (3&-r_o,cu) are also listed in fig.2 The coupl- 
ing constants were measured from the antiphase 
peak separation in high resolution phase sensitive 
COSY cross sections parallel to F2 with a digital 
resolution of 1.2 Hz/point. No allowance was 
made for possible distortions arising from peak 
overlap [23]. 
The observed NOE patterns and 3JNH.a~H values 
are diagnostic for protein secondary structure 
[ 11,121. For example P-sheet or extended confor- 
mations lead to strong daN NOES and large 
‘&u-&H values, while a-helix leads to strong dNN 
NOES and small values of 3JNH_a~H. Many of the 
3&u_&.r values listed in fig.2 are in the range 8-10 
Hz and daN NOES are prevalent, suggesting that 
much of the protein is in an extended or P-sheet 
conformation. 
Features of the tertiary structure can also be 
deduced from the pattern of slowly exchanging 
amide hydrogens and longer range NOES. For ex- 
ample NOES are observed between the cvCH 
resonances of Cys-31 and Cys-20, and between 
those of Cys-33 and Gly-18. At 30°C the Tyr-22 
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Fig.1. The ‘fingerprint’ regions of the NOESY (mixing time = 140 ms) and COSY spectra of l-48 hEGF in 90% 
H20/10% D20. The NH-&H COSY cross peaks for residues 29-35 are indicated and dmN connectivities between adja- 
cent residues are marked in the NOESY spectrum. At this temperature (30°C) the NH-&H COSY peak for Cys-33 
is obscured by the Hz0 resonance. This connectivity was observed in a COSY experiment recorded at 50°C and its posi- 
tion is indicated with the dashed box. 
&H resonance is obscured by irradiation of the 
solvent peak but it is visible at 26°C in DzO, when 
an NOE is observed to the cvCH resonance of 
Tyr-29. This indicates that these six residues are in- 
volved in an antiparallel &sheet [ 111. Residues in 
such sheets alternate sequentially between those in 
which the &H faces the opposite strand and those 
in which the backbone NH is hydrogen bonded to 
a carbonyl of the neighbouring strand. Residues 
for which &H-&H interstrand NOES are 
observed should, thus, be preceded and followed 
by residues with slowly exchanging backbone 
amide protons. Since slowly exchanging protons 
are observed at positions 19, 21, 23, 28, 30, 32 and 
34 (fig.2), this confirms the antiparallel P-sheet in- 
volving residues 18-23 and 28-34. 
The pairing of residues 23 and 28 forces residues 
24-27 to adopt a ‘hairpin’ turn [24] and leads to 
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Fig.2. A summary of the NMR data relevant to the structure of l-48 hEGF. At the top of the diagram is shown the 
hEGF sequence with the location of the disulphide bonds. The observable daN, dNN and d@N connectivities are marked 
directly underneath. The height of the bars indicates the approximate magnitude of the NOES. Below this, the residues 
for which the uCH resonances are obscured at 30°C by irradiation of Hz0 are indicated (+). The values of 3J~~_a~- 
(in Hz) are then listed. Finally the locations of the backbone amide protons which are slowly exchanging in D20 are 
indicated (*). 
the dp+N OES observed for these residues (fig.2). 
A type II turn [24] is located between residues 34 
and 37, characterised [l 1] by a strong dolN connec- 
tivity between Val-35 and Gly-36, a small 3J~~-olc~ 
for Val-35, a dNN connectivity between Gly-36 and 
Tyr-37 and the involvement of the Tyr-37 amide 
proton in a hydrogen bond. Confirmatory 
evidence comes from the NOES between 
resonances of the side chains of Val-34 and Tyr-37. 
The location of another turn between residues 41 
and 44 is suggested by the sequential NOES in this 
region (fig.2). This would allow the Tyr-44 amide 
proton to be hydrogen bonded to the Arg-41 car- 
bony1 and account for its slow exchange rate. It is 
not yet possible, however, to classify unam- 
biguously this turn. Further turns are expected be- 
tween the disulphide linked residues 6 and 20, 
possibly in the vicinity of Gly-12. There is no 
evidence for helix. The N- and C-terminal regions 
appear to be extended with the N-terminus 
relatively mobile as judged by its relatively sharp 
resonances. 
4. CONCLUSIONS 
‘H NMR spectr a of hEGF have been analysed 
and some aspects of the solution structure iden- 
tified. The major structural feature of hEGF is the 
antiparallel &sheet, involving residues 18-23 and 
28-34. It is interesting to note that one residue 
from each disulphide bridge is located in this /3- 
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sheet region. The location of the &sheet is in good 
agreement with the structure prediction of Holla- 
day et al. [25] for murine EGF, although there are 
important differences; residues 34-37, for exam- 
ple, were predicted to be in a sheet while we find 
this region is involved in a type II turn. A complete 
determination of the solution structure of human 
EGF using distance constraints from NMR is now 
required. We are beginning to apply both the 
restrained molecular dynamics [26] and the 
distance geometry approaches [27] to this task. 
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